13D Filing: Edenbrook Capital, Llc and Yume Inc (NYSE:YUME)

Page 4 of 8 – SEC Filing

CUSIP No.
98872B104
Item 1.
Security and Issuer.
This statement on Schedule 13D (the “Schedule 13D”) relates to the Common Stock, par value $0.001 (the “Common Stock”), of YuMe, Inc. (the “Issuer”). The address of the principal executive offices of the Issuer is 1204 Middlefield Road, Redwood City, CA, 94063.
Item 2.
Identity and Background.
(a)-(c)
This Schedule 13D is being filed jointly by (i) Edenbrook Capital, LLC (“Edenbrook”), a New York limited liability company, as the investment manager to certain private investment funds, with respect to Common Stock owned by such private investment funds, and (ii) Jonathan Brolin (“Mr. Brolin”), a United States citizen and the principal of Edenbrook with respect to the Common Stock owned by such private investment funds (collectively, the “Reporting Persons”).
Mr. Brolin’s present principal occupation or employment is acting as a private investor.  The principal business address of Mr. Brolin and Edenbrook is 2 Depot Plaza, Bedford Hills, New York 10507. Mr. Brolin is the Managing Member of Edenbrook and, as such, is in the position to determine the investment and voting decisions made by Edenbrook.
(d)
None of the Reporting Persons has, during the last five years, been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).
(e)
None of the Reporting Persons has, during the last five years, been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, Federal or state securities laws or finding any violation with respect to such laws.
Item 3.
Source and Amount of Funds or Other Consideration.
The net investment costs (including commissions, if any) of the Common Stock directly owned by the private investment funds advised by Edenbrook is approximately $7,356,055.  The Common Stock was purchased with the investment capital of the private investment funds advised by Edenbrook.
Item 4.
Purpose of Transaction.
No material changes have been made to the Reporting Persons’ Item 4 disclosure in the 13D/A previously filed on September 14, 2016.

Follow Yume Inc (NYSE:YUME)